Covid-19: Razvoj vakcine, imunitet i primena medikamenata

[Tsai]

nikad se ne zna, mozda dobije neki kramer protiv kramera

[Jozef K.]

Kinezi i dalje tvrde da je samo 20% simptomatski. Neverovatno je da njima iko išta više veruje.

Studija Wuhan

 

[vememah]

 

[Dankan Ajdaho]

https://www.b92.net/zdravlje/vesti.php?yyyy=2021&mm=03&dd=21&nav_id=1830493

[Moracikus]

Hahahahahaa

Koji rollercoaster ova vakcina

[Dankan Ajdaho]

1 hour ago, Moracikus said:

Hahahahahaa

Koji rollercoaster ova vakcina

 

 

https://www.astrazeneca.com/media-centre/press-releases/2021/astrazeneca-us-vaccine-trial-met-primary-endpoint.html

[vememah]

Malo konteksta i detalja:

 

 

 

Quote

The AstraZeneca US Phase III trial of AZD1222 demonstrated statistically significant vaccine efficacy of 79% at preventing symptomatic COVID-19 and 100% efficacy at preventing severe disease and hospitalisation.

This interim safety and efficacy analysis was based on 32,449 participants accruing 141 symptomatic cases of COVID-19. The trial had a 2:1 randomisation of vaccine to placebo.

Vaccine efficacy was consistent across ethnicity and age. Notably, in participants aged 65 years and over, vaccine efficacy was 80%.

The vaccine was well tolerated, and the independent data safety monitoring board (DSMB) identified no safety concerns related to the vaccine. The DSMB conducted a specific review of thrombotic events, as well as cerebral venous sinus thrombosis (CVST) with the assistance of an independent neurologist. The DSMB found no increased risk of thrombosis or events characterised by thrombosis among the 21,583 participants receiving at least one dose of the vaccine. The specific search for CVST found no events in this trial.
...
Amongst participants in the interim analysis, approximately 79% were white/Caucasian, 8% black/African American, 4% native American and 4% Asian, and 22% of participants were Hispanic.

Approximately 20% of participants were 65 years and over, and approximately 60% had co-morbidities associated with an increased risk for progression of severe COVID-19, such as diabetes, severe obesity or cardiac disease.

This AstraZeneca-led US Phase III trial included two doses administered at a four week interval.

https://www.astrazeneca.com/media-centre/press-releases/2021/astrazeneca-us-vaccine-trial-met-primary-endpoint.html

Edited March 22, 2021 by vememah

[Filozof manijak]

KAko reče ona bosanka političarka: vakcina za sirotinju.  

[vememah]

 

[ToniAdams]

pa ok, al i dalje je astra zeneka najmanje ucinkovita od ovih prihvacenih usvijet. ili se varam?

[nick1986]

Ako 100% sprecava hospitalizaciju i smrt sve drugo je nevazno

[vememah]

9 minutes ago, ToniAdams said:

pa ok, al i dalje je astra zeneka najmanje ucinkovita od ovih prihvacenih usvijet. ili se varam?

 

Pa OK, al i dalje je u svetu dato manje od 6 doza na 100 stanovnika.

[ToniAdams]

6 minutes ago, nick1986 said:

Ako 100% sprecava hospitalizaciju i smrt sve drugo je nevazno

kapiram da nisi primio fajzera cim ovako razmisljas

[nick1986]

Primio sam Astru pre 12 dana al sam trenutno sa simptomima cekam rezultat. Ako radi dovoljno da prodjem bez upale pluca puna kapa.

[ToniAdams]

malo ti za sricu triba